These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 16150868)

  • 1. Interleukin-1alpha inhibits insulin signaling with phosphorylating insulin receptor substrate-1 on serine residues in 3T3-L1 adipocytes.
    He J; Usui I; Ishizuka K; Kanatani Y; Hiratani K; Iwata M; Bukhari A; Haruta T; Sasaoka T; Kobayashi M
    Mol Endocrinol; 2006 Jan; 20(1):114-24. PubMed ID: 16150868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes.
    Tremblay F; Gagnon A; Veilleux A; Sorisky A; Marette A
    Endocrinology; 2005 Mar; 146(3):1328-37. PubMed ID: 15576463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic tumor necrosis factor-alpha treatment causes insulin resistance via insulin receptor substrate-1 serine phosphorylation and suppressor of cytokine signaling-3 induction in 3T3-L1 adipocytes.
    Ishizuka K; Usui I; Kanatani Y; Bukhari A; He J; Fujisaka S; Yamazaki Y; Suzuki H; Hiratani K; Ishiki M; Iwata M; Urakaze M; Haruta T; Kobayashi M
    Endocrinology; 2007 Jun; 148(6):2994-3003. PubMed ID: 17379643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rescuing 3T3-L1 adipocytes from insulin resistance induced by stimulation of Akt-mammalian target of rapamycin/p70 S6 kinase (S6K1) pathway and serine phosphorylation of insulin receptor substrate-1: effect of reduced expression of p85alpha subunit of phosphatidylinositol 3-kinase and S6K1 kinase.
    Adochio R; Leitner JW; Hedlund R; Draznin B
    Endocrinology; 2009 Mar; 150(3):1165-73. PubMed ID: 18948408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression.
    Jager J; Grémeaux T; Cormont M; Le Marchand-Brustel Y; Tanti JF
    Endocrinology; 2007 Jan; 148(1):241-51. PubMed ID: 17038556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G protein-coupled receptor kinase 2 mediates endothelin-1-induced insulin resistance via the inhibition of both Galphaq/11 and insulin receptor substrate-1 pathways in 3T3-L1 adipocytes.
    Usui I; Imamura T; Babendure JL; Satoh H; Lu JC; Hupfeld CJ; Olefsky JM
    Mol Endocrinol; 2005 Nov; 19(11):2760-8. PubMed ID: 15994203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of insulin sensitivity by free fatty acids requires activation of multiple serine kinases in 3T3-L1 adipocytes.
    Gao Z; Zhang X; Zuberi A; Hwang D; Quon MJ; Lefevre M; Ye J
    Mol Endocrinol; 2004 Aug; 18(8):2024-34. PubMed ID: 15143153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic endothelin-1 treatment leads to heterologous desensitization of insulin signaling in 3T3-L1 adipocytes.
    Ishibashi KI; Imamura T; Sharma PM; Huang J; Ugi S; Olefsky JM
    J Clin Invest; 2001 May; 107(9):1193-202. PubMed ID: 11342583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent activation of phosphatidylinositol 3-kinase causes insulin resistance due to accelerated insulin-induced insulin receptor substrate-1 degradation in 3T3-L1 adipocytes.
    Egawa K; Nakashima N; Sharma PM; Maegawa H; Nagai Y; Kashiwagi A; Kikkawa R; Olefsky JM
    Endocrinology; 2000 Jun; 141(6):1930-5. PubMed ID: 10830273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three mitogen-activated protein kinases inhibit insulin signaling by different mechanisms in 3T3-L1 adipocytes.
    Fujishiro M; Gotoh Y; Katagiri H; Sakoda H; Ogihara T; Anai M; Onishi Y; Ono H; Abe M; Shojima N; Fukushima Y; Kikuchi M; Oka Y; Asano T
    Mol Endocrinol; 2003 Mar; 17(3):487-97. PubMed ID: 12554784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of feedback regulation of insulin receptor substrate-1 phosphorylation in primary adipocytes.
    Hers I; Tavaré JM
    Biochem J; 2005 Jun; 388(Pt 2):713-20. PubMed ID: 15713122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1.
    Haruta T; Uno T; Kawahara J; Takano A; Egawa K; Sharma PM; Olefsky JM; Kobayashi M
    Mol Endocrinol; 2000 Jun; 14(6):783-94. PubMed ID: 10847581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone induces cellular insulin resistance by uncoupling phosphatidylinositol 3-kinase and its downstream signals in 3T3-L1 adipocytes.
    Takano A; Haruta T; Iwata M; Usui I; Uno T; Kawahara J; Ueno E; Sasaoka T; Kobayashi M
    Diabetes; 2001 Aug; 50(8):1891-900. PubMed ID: 11473053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II impairs the insulin signaling pathway promoting production of nitric oxide by inducing phosphorylation of insulin receptor substrate-1 on Ser312 and Ser616 in human umbilical vein endothelial cells.
    Andreozzi F; Laratta E; Sciacqua A; Perticone F; Sesti G
    Circ Res; 2004 May; 94(9):1211-8. PubMed ID: 15044323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1.
    Ozes ON; Akca H; Mayo LD; Gustin JA; Maehama T; Dixon JE; Donner DB
    Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4640-5. PubMed ID: 11287630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progesterone inhibits glucose uptake by affecting diverse steps of insulin signaling in 3T3-L1 adipocytes.
    Wada T; Hori S; Sugiyama M; Fujisawa E; Nakano T; Tsuneki H; Nagira K; Saito S; Sasaoka T
    Am J Physiol Endocrinol Metab; 2010 Apr; 298(4):E881-8. PubMed ID: 20071559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-derived growth factor inhibits insulin stimulation of insulin receptor substrate-1-associated phosphatidylinositol 3-kinase in 3T3-L1 adipocytes without affecting glucose transport.
    Staubs PA; Nelson JG; Reichart DR; Olefsky JM
    J Biol Chem; 1998 Sep; 273(39):25139-47. PubMed ID: 9737973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor alpha-mediated insulin resistance, but not dedifferentiation, is abrogated by MEK1/2 inhibitors in 3T3-L1 adipocytes.
    Engelman JA; Berg AH; Lewis RY; Lisanti MP; Scherer PE
    Mol Endocrinol; 2000 Oct; 14(10):1557-69. PubMed ID: 11043572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERK1/2 activation by angiotensin II inhibits insulin-induced glucose uptake in vascular smooth muscle cells.
    Izawa Y; Yoshizumi M; Fujita Y; Ali N; Kanematsu Y; Ishizawa K; Tsuchiya K; Obata T; Ebina Y; Tomita S; Tamaki T
    Exp Cell Res; 2005 Aug; 308(2):291-9. PubMed ID: 15921682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism for differential effect of protein-tyrosine phosphatase 1B on Akt versus mitogen-activated protein kinase in 3T3-L1 adipocytes.
    Shimizu S; Maegawa H; Egawa K; Shi K; Bryer-Ash M; Kashiwagi A
    Endocrinology; 2002 Dec; 143(12):4563-9. PubMed ID: 12446583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.